🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update

Journal of Cardiovascular Development and Disease(2025)10.3390/jcdd12060207Source: DataRank Database

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update is a research paper published in Journal of Cardiovascular Development and Disease (2025). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)Impact (FWCI 37.51)OA: goldTopics (21)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Fahimeh Varzideh ORCID,Scott Wilson ORCID,Urna Kansakar ORCID,Stanislovas S. Jankauskas ORCID,Gaetano Santulli ORCID

Live enrichment

PubMed:40558642 OpenAlex:https://openalex.org/W4410901021

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: R01-HL164772

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: R01-HL159062

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: R01-HL146691

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: T32-HL144456

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: T32-HL172255

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: R01-DK123259

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: R01-DK033823

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: UL1-TR002556-06

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: UM1-TR004400

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: 24IPA1268813

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: AHA-22POST915561

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: AHA 24POST1195524

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: 23POST1026190

National Institutes of Health (NIH): National Heart, Lung, and Blood Institute

Grant: T32-HL-172255

NHLBI NIH HHS

Grant: R01 HL164772

NIDDK NIH HHS

Grant: R01 DK123259

NIDDK NIH HHS

Grant: R01 DK033823

NHLBI NIH HHS

Grant: R01 HL159062

NHLBI NIH HHS

Grant: T32 HL172255

NCATS NIH HHS

Grant: UL1 TR002556

NHLBI NIH HHS

Grant: R01 HL146691

NHLBI NIH HHS

Grant: T32 HL144456

NCATS NIH HHS

Grant: UM1 TR004400

NIH HHS

Grant: 1R01HL164772-25

FWCI

37.51

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2308-3425/12/6/207/pdf?version=1748587138

publisherhttps://www.mdpi.com/2308-3425/12/6/207/pdf?version=1748587138

publisherhttps://www.mdpi.com/2308-3425/12/6/207/pdf

journalhttps://doi.org/10.3390/jcdd12060207

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40558642

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationCancer Treatment and PharmacologyCarbon Nanotubes in Composites

Keywords

CardiotoxicityDoxorubicinAnthracyclineMedicineCancerTopoisomeraseBreast cancerPharmacologyChemotherapyInternal medicineOncologyBiologyDNADNA damageanthracyclinescardiomyopathycell deathheart failure

Sustainable Development Goals

SDG 0: Good health and well-being